BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18818422)

  • 1. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
    Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
    Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of glycan targeting antibodies to identify cancer-associated glycoproteins in plasma of breast cancer patients.
    Cho W; Jung K; Regnier FE
    Anal Chem; 2008 Jul; 80(14):5286-92. PubMed ID: 18558770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.
    Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST
    Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
    Itoh N; Sakaue S; Nakagawa H; Kurogochi M; Ohira H; Deguchi K; Nishimura S; Nishimura M
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1069-77. PubMed ID: 17666489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
    Laessig D; Nagel D; Heinemann V; Untch M; Kahlert S; Bauerfeind I; Stieber P
    Anticancer Res; 2007; 27(4A):1963-8. PubMed ID: 17649806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.
    Bones J; Byrne JC; O'Donoghue N; McManus C; Scaife C; Boissin H; Nastase A; Rudd PM
    J Proteome Res; 2011 Mar; 10(3):1246-65. PubMed ID: 21142185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia.
    Stanta JL; Saldova R; Struwe WB; Byrne JC; Leweke FM; Rothermund M; Rahmoune H; Levin Y; Guest PC; Bahn S; Rudd PM
    J Proteome Res; 2010 Sep; 9(9):4476-89. PubMed ID: 20578731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum.
    Storr SJ; Royle L; Chapman CJ; Hamid UM; Robertson JF; Murray A; Dwek RA; Rudd PM
    Glycobiology; 2008 Jun; 18(6):456-62. PubMed ID: 18332077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation.
    Bones J; Mittermayr S; O'Donoghue N; Guttman A; Rudd PM
    Anal Chem; 2010 Dec; 82(24):10208-15. PubMed ID: 21073175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry.
    Valmu L; Alfthan H; Hotakainen K; Birken S; Stenman UH
    Glycobiology; 2006 Dec; 16(12):1207-18. PubMed ID: 16880503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
    Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.
    Saldova R; Royle L; Radcliffe CM; Abd Hamid UM; Evans R; Arnold JN; Banks RE; Hutson R; Harvey DJ; Antrobus R; Petrescu SM; Dwek RA; Rudd PM
    Glycobiology; 2007 Dec; 17(12):1344-56. PubMed ID: 17884841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
    Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
    FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
    Comunale MA; Lowman M; Long RE; Krakover J; Philip R; Seeholzer S; Evans AA; Hann HW; Block TM; Mehta AS
    J Proteome Res; 2006 Feb; 5(2):308-15. PubMed ID: 16457596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
    Arnold JN; Saldova R; Hamid UM; Rudd PM
    Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
    Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
    Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of altered N-glycan profiles in whole serum from rheumatoid arthritis patients.
    Nakagawa H; Hato M; Takegawa Y; Deguchi K; Ito H; Takahata M; Iwasaki N; Minami A; Nishimura S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):133-7. PubMed ID: 17392038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.
    Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S
    J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.